スポンサーリンク
Division Of Internal Medicine National Cancer Center Hospital | 論文
- Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
- 日本人におけるGSTT1及びGSTM1の遺伝子多型の同定及びハプロタイプ構造の解析
- Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population
- Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects : SLCO1B1^*17 is More Prevalent Than ^*15
- Genetic Variation and Haplotype Structure of the ABC Transporter Gene ABCG2 in a Japanese Population
- Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days
- Twenty-six Novel Single Nucleotide Polymorphisms and their Frequencies of the NR113 (CAR) Gene in a Japanese Population
- Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples
- Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor
- Synergistic interactions between the synthetic retinoid tamibarotene and glucocorticoids in human myeloma cells
- A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer
- Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway
- Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft models
- Reversal of Cisplatin Resistance by the 1,4-Benzothiazepine Derivative, JTV-519
- CPT-11 Alters the Circadian Rhythm of Dihydropyrimidine Dehydrogenase mRNA in Mouse Liver
- High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients
- Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors
- Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma
- The role of a common TNNT2 polymorphism in cardiac hypertrophy
- Bodyweight change during the first 5 days of chemotherapy as an indicator of cisplatin renal toxicity